Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation

Journal of Clinical Investigation

Volumn 126, Issue 10, 2016, Pages 3783-3798

  Yost, Christian C ^a   Schwertz, Hansjörg ^a   Cody, Mark J ^a   Wallace, Jared A ^a   Campbell, Robert A ^a   Vieira De Abreu, Adriana ^a   Araujo, Claudia V ^a   Schubert, Sebastian ^a,b   Harris, Estelle S ^a   Rowley, Jesse W ^a   Rondina, Matthew T ^a   Fulcher, James M ^a   Koening, Curry L ^a   Weyrich, Andrew S ^a   Zimmerman, Guy A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIAL TOXIN; NEONATAL NET INHIBITORY FACTOR; NEUTROPHIL INHIBITORY FACTOR; NNIF RELATED PEPTIDE; PEPTIDYL ARGININE DEIMINASE 4; PROTEIN ARGININE DEIMINASE; TOXIN; UNCLASSIFIED DRUG; CANCER-RECOGNITION, IMMUNEDEFENSE SUPPRESSION, SERINE PROTEASE PROTECTION PEPTIDE; HISTONE; LIPOPOLYSACCHARIDE; NNIF PEPTIDE, HUMAN; PLASMA PROTEIN; TUMOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; EXTRACELLULAR TRAP; HISTONE CITRULLINATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; INFECTION; INFLAMMATION; MALE; MORTALITY; MOUSE; MOUSE MODEL; NEUTROPHIL; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE INJURY; UMBILICAL CORD BLOOD; ANIMAL; C57BL MOUSE; CELL CULTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; FETUS BLOOD; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; BLOOD PROTEINS; CELLS, CULTURED; CHROMATIN ASSEMBLY AND DISASSEMBLY; EXTRACELLULAR TRAPS; FETAL BLOOD; HISTONES; HUMANS; INFANT, NEWBORN; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEUTROPHILS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84991632804     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI83873     Document Type: Article

References (75)

1. Sorensen OE, Borregaard N. Neutrophil extracellular traps -the dark side of neutrophils. J Clin Invest. 2016;126(5):1612-1620.
2. Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin?. J Cell Biol. 2012;198(5):773-783.
3. Yipp BG, Kubes P. NETosis: how vital is it? Blood. 2013;122(16):2784-2794.
4. Brinkmann V, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-1535.
5. Yipp BG, et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med. 2012;18(9):1386-1393.
6. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191(3):677-691.
7. Wang Y, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009;184(2):205-213.
8. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853-1862.
9. Kolaczkowska E, et al. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat Commun. 2015;6:6673.
10. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev. 2007;219:88-102.
11. Bianchi M, et al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood. 2009;114(13):2619-2622.
12. Xu J, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318-1321.
13. Clark SR, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13(4):463-469.
14. McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe. 2012;12(3):324-333.
15. Caudrillier A, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012;122(7):2661-2671.
16. Sayah DM, et al. Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2015;191(4):455-463.
17. Chen G, Zhang D, Fuchs TA, Manwani D, Wagner DD, Frenette PS. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood. 2014;123(24):3818-3827.
18. Lood C, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22(2):146-153.
19. Fuchs TA, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107(36):15880-15885.
20. Pillai PS, et al. Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science. 2016;352(6284):463-466.
21. McDonagh S, Maidji E, Ma W, Chang HT, Fisher S, Pereira L. Viral and bacterial pathogens at the maternal-fetal interface. J Infect Dis. 2004;190(4):826-834.
22. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5(7):e177.
23. Jost T, Lacroix C, Braegger CP, Chassard C. New insights in gut microbiota establishmentin healthy breast fed neonates. PLoS One. 2012;7(8):e44595.
24. Deshmukh HS, et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med. 2014;20(5):524-530.
25. Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol. 2014;35(7):299-310.
26. Adkins B. Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state. Immunol Res. 2013;57(1-3):246-257.
27. Elahi S, et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature. 2013;504(7478):158-162.
28. Yost CC, et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood. 2009;113(25):6419-6427.
29. Marcos V, et al. Delayed but functional neutrophil extracellular trap formation in neonates. Blood. 2009;114(23):4908-4911; author reply 4911.
30. McInturff AM, et al. Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α. Blood. 2012;120(15):3118-3125.
31. Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med. 2011;105(8):1129-1139.
32. Jonigk D, et al. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci U S A. 2013;110(37):15007-15012.
33. Farley K, Stolley JM, Zhao P, Cooley J, Remold-O'Donnell E. A serpinB1 regulatory mechanism is essential for restricting neutrophil extracellular trap generation. J Immunol. 2012;189(9):4574-4581.
34. Frenzel E, et al. Does augmentation with alpha1-antitrypsin affect neutrophil extracellular traps formation? Int J Biol Sci. 2012;8(7):1023-1025.
35. Cercek L, Cercek B. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part I. Isolation, amino acid sequence, homology, and origin. Cancer Detect Prev. 1992;16(5-6):305-319.
36. Cercek L, Cercek B. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part II. Immunedefense suppressive effects of the CRISPPs peptide. Cancer Detect Prev. 1993;17(3):433-445.
37. Cercek L, Cercek B. Cancer-associated SCM-recognition, immune defense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition. Cancer Detect Prev. 1993;17(3):447-454.
38. Saffarzadeh M, Preissner KT. Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection. Curr Opin Hematol. 2013;20(1):3-9.
39. Niemann MA, Narkates AJ, Miller EJ. Isolation and serine protease inhibitory activity of the 44-residue, C-terminal fragment of alpha 1-antitrypsin from human placenta. Matrix. 1992;12(3):233-241.
40. Niemann MA, Baggott JE, Miller EJ. Binding of SPAAT, the 44-residue C-terminal peptide of alpha 1-antitrypsin, to proteins of the extracellular matrix. J Cell Biochem. 1997;66(3):346-357.
41. Fuchs TA, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231-241.
42. Pilsczek FH, et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol. 2010;185(12):7413-7425.
43. Saitoh T, et al. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe. 2012;12(1):109-116.
44. Jenne CN, et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe. 2013;13(2):169-180.
45. Raftery MJ, et al. β2 integrin mediates hantavirusinduced release of neutrophil extracellular traps. J Exp Med. 2014;211(7):1485-1497.
46. Cheung R, et al. Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice. J Clin Invest. 2011;121(11):4446-4461.
47. Gladwin MT, Ofori-Acquah SF. Erythroid DAMPs drive inflammation in SCD. Blood. 2014;123(24):3689-3690.
48. Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol. 2012;34(1):5-30.
49. Branzk N, Papayannopoulos V. Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol. 2013;35(4):513-530.
50. Tanaka K, et al. In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model. PLoS ONE. 2014;9(11):e111888.
51. Hubbard WJ, et al. Cecal ligation and puncture. Shock. 2005;24(Suppl 1):52-57.
52. Araujo CV, et al. A PPARγ agonist enhances bacterial clearance through neutrophil extracellular trap formation and improves survival in sepsis. Shock. 2016;45(4):393-403.
53. Czaikoski PG, et al. Neutrophil extracellular traps induce organ damage during experimental and clinical Sepsis. PLoS One. 2016;11(2):e0148142.
54. Nathan C. Points of control in inflammation. Nature. 2002;420(6917):846-852.
55. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428-435.
56. Arck PC, Hecher K. Fetomaternal immune crosstalk and its consequences for maternal and offspring's health. Nat Med. 2013;19(5):548-556.
57. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7(5):379-390.
58. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol. 2005;66(11):1146-1154.
59. Sangaletti S, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood. 2012;120(15):3007-3018.
60. Castellucci M, Theelen T, Pompili E, Fumagalli L, De Renzis G, Muhlhauser J. Immunohistochemical localization of serine-protease inhibitors in the human placenta. Cell Tissue Res. 1994;278(2):283-289.
61. Frochaux V, Hildebrand D, Talke A, Linscheid MW, Schluter H. Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue. PLoS One. 2014;9(10):e109483.
62. Niemann MA, Baggott JE, Miller EJ. Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsin. Biochim Biophys Acta. 1997;1340(1):123-130.
63. Pei D, Majmudar G, Weiss SJ. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem. 1994;269(41):25849-25855.
64. Cools-Lartigue J, et al. Neutrophil extracellular traps sequester circulating tumor cells promote metastasis. J Clin Invest. 2013;123(8):3446-3458.
65. Byrd AS, et al. NETosis in Neonates: Evidence of a reactive oxygen species-independent pathway in response to fungal challenge. J Infect Dis. 2016;213(4):634-639.
66. Schauer C, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511-517.
67. Zabieglo K, et al. The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps. J Leukoc Biol. 2015;98(1):99-106.
68. Yost CC. Toward the "ideal" inhibitor of NETs. Blood. 2014;123(16):2439-2440.
69. Lewis HD, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015;11(3):189-191.
70. Wildhagen KC, et al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood. 2014;123(7):1098-1101.
71. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173-182.
72. Weyrich AS, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97(6):1525-1534.
73. Hill HR, et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet. 1974;2(7881):617-619.
74. van Velzen JF, Laros-van Gorkom BA, Pop GA, van Heerde WL. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers. Thromb Res. 2012;130(1):92-98.
75. Evangelista V, et al. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. Blood. 1996;88(11):4183-4194.